Chiang Mai Ram Medical Business 将来の成長

Future 基準チェック /06

We currently don't have sufficient analyst coverage to forecast growth and revenue for Chiang Mai Ram Medical Business.

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare 収益成長	10.7%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Chiang Mai Ram Medical Business は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SET:CMR - アナリストの将来予測と過去の財務データ ( )THB Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	5,345	279	620	970	N/A
3/31/2024	5,243	242	627	963	N/A
12/31/2023	5,144	218	627	1,015	N/A
9/30/2023	4,980	160	696	1,032	N/A
6/30/2023	4,906	187	804	1,112	N/A
3/31/2023	5,242	453	931	1,284	N/A
12/31/2022	5,269	504	749	1,120	N/A
9/30/2022	5,475	577	490	1,058	N/A
6/30/2022	5,210	564	149	770	N/A
3/31/2022	4,575	326	-184	579	N/A
12/31/2021	4,244	292	-243	638	N/A
9/30/2021	3,858	258	-334	680	N/A
6/30/2021	3,742	211	-567	673	N/A
3/31/2021	3,634	182	-773	600	N/A
12/31/2020	3,717	198	-786	619	N/A
9/30/2020	3,758	201	-717	702	N/A
6/30/2020	3,847	170	-320	845	N/A
3/31/2020	4,070	247	-310	958	N/A
12/31/2019	3,965	158	-227	904	N/A
9/30/2019	3,924	181	-17	729	N/A
6/30/2019	3,906	247	-41	698	N/A
3/31/2019	3,871	271	360	692	N/A
12/31/2018	3,969	375	303	642	N/A
9/30/2018	3,961	414	481	839	N/A
6/30/2018	4,020	489	564	915	N/A
3/31/2018	3,929	481	N/A	812	N/A
12/31/2017	3,775	440	N/A	822	N/A
9/30/2017	3,719	422	N/A	743	N/A
6/30/2017	3,603	404	N/A	755	N/A
3/31/2017	3,534	366	N/A	732	N/A
12/31/2016	3,505	388	N/A	746	N/A
9/30/2016	3,437	386	N/A	889	N/A
6/30/2016	3,389	402	N/A	715	N/A
3/31/2016	3,295	433	N/A	768	N/A
12/31/2015	3,314	501	N/A	853	N/A
9/30/2015	3,222	509	N/A	593	N/A
6/30/2015	3,081	445	N/A	688	N/A
3/31/2015	3,025	437	N/A	659	N/A
12/31/2014	2,922	387	N/A	524	N/A
9/30/2014	2,849	379	N/A	610	N/A
6/30/2014	2,908	449	N/A	612	N/A
3/31/2014	2,829	429	N/A	646	N/A
12/31/2013	2,676	367	N/A	631	N/A

アナリストによる今後の成長予測

収入対貯蓄率: Insufficient data to determine if CMR's forecast earnings growth is above the savings rate (2%).

収益対市場: Insufficient data to determine if CMR's earnings are forecast to grow faster than the TH market

高成長収益: Insufficient data to determine if CMR's earnings are expected to grow significantly over the next 3 years.

収益対市場: Insufficient data to determine if CMR's revenue is forecast to grow faster than the TH market.

高い収益成長: Insufficient data to determine if CMR's revenue is forecast to grow faster than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: Insufficient data to determine if CMR's Return on Equity is forecast to be high in 3 years time

Chiang Mai Ram Medical Business 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Second quarter 2024 earnings released: EPS: ฿0.007 (vs ฿0.002 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: ฿0.02 (vs ฿0.016 in 1Q 2023)

Upcoming dividend of ฿0.055 per share

Dividend reduced to ฿0.055

Chiang Mai Ram Medical Business Public Company Limited, Annual General Meeting, Apr 29, 2024

Chiang Mai Ram Medical Business Public Company Limited Proposes Annual Dividend from January 1, 2023 to December 31, 2023, Payable on May 24, 2024

Chiang Mai Ram Medical Business Public Company Limited Announces Board Resignations

Third quarter 2023 earnings released: EPS: ฿0.02 (vs ฿0.026 in 3Q 2022)

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: ฿0.002 loss per share (vs ฿0.064 profit in 2Q 2022)

Chiang Mai Ram Medical Business Public Company Limited announced that it expects to receive TWD 129.6 million in funding

First quarter 2023 earnings released: EPS: ฿0.02 (vs ฿0.029 in 1Q 2022)

Upcoming dividend of ฿0.066 per share at 2.5% yield

Second quarter 2022 earnings released: EPS: ฿0.06 (vs ฿0.005 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: ฿0.03 (vs ฿0.02 in 1Q 2021)

Investor sentiment improved over the past week

Upcoming dividend of ฿0.065 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Chiang Mai Ram Medical Business Public Company Limited Proposes Annual Dividend Payment for the Period Ended December 31, 2021, Payable on May 24, 2022

Third quarter 2021 earnings released: EPS ฿0.022 (vs ฿0.011 in 3Q 2020)

Second quarter 2021 earnings released: EPS ฿0.005 (vs ฿0.002 loss in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Chairman of the Board Racha Somburanasin has left the company

Independent Director has left the company

First quarter 2021 earnings released: EPS ฿0.02 (vs ฿0.025 in 1Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS ฿0.05 (vs ฿0.039 in FY 2019)

Chiang Mai Ram Medical Business Public Company Limited, Annual General Meeting, Apr 28, 2021

New 90-day high: ฿1.84

New 90-day low: ฿1.74

New 90-day low: ฿1.76

Third quarter 2020 earnings released: EPS ฿0.011

New 90-day low: ฿1.78

New 90-day low: ฿1.80

New 90-day low - ฿1.85

First half earnings released

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘